Medical Imaging Phantoms Gain Traction with Expansion of Advanced Diagnostic and Interventional Procedures

The global medical imaging phantoms market is witnessing steady growth, driven by rising emphasis on patient safety, radiation dose reduction, and the expanding adoption of advanced diagnostic and interventional imaging procedures. Valued at US$ 188.3 million in 2022, the market is projected to grow at a compound annual growth rate (CAGR) of 3.6% from 2023 to 2031, reaching US$ 257.7 million by the end of 2031. Medical imaging phantoms are specially designed objects that simulate the physical and radiological properties of human tissues. They are widely used to test, calibrate, and validate medical imaging systems such as X-ray, fluoroscopy, ultrasound, CT, MRI, and nuclear imaging devices. By serving as reliable stand-ins for human anatomy, phantoms enable healthcare professionals and researchers to conduct repeated scans under controlled conditions without exposing patients to unnecessary radiation. Rising Focus on Patient Safety and Dose Optimization One of the key drivers of the